Association between patient-provider communication and lung cancer stigma

Megan Johnson Shen, Heidi A. Hamann, Anna J. Thomas, Jamie S. Ostroff

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: The majority (95 %) of lung cancer patients report stigma, with 48 % of lung cancer patients specifically reporting feeling stigmatized by their medical providers. Typically associated with the causal link to smoking and the historically poor prognosis, lung cancer stigma can be seen as a risk factor for poor psychosocial and medical outcomes in the context of lung cancer diagnosis and treatment. Thus, modifiable targets for lung cancer stigma-reducing interventions are needed. The present study sought to test the hypothesis that good patient-provider communication is associated with lower levels of lung cancer stigma. Methods: Lung cancer patients (n = 231) across varying stages of disease participated in a cross-sectional, multisite study designed to understand lung cancer stigma. Patients completed several survey measures, including demographic and clinical characteristics, a measure of patient-provider communication (Consumer Assessment of Healthcare Providers and Systems Program or CAHPS), and a measure of lung cancer stigma (Cataldo Lung Cancer Stigma Scale). Results: As hypothesized, results indicated that good patient-provider communication was associated with lower levels of lung cancer stigma (r = −0.18, p <0.05). These results remained significant, even when controlling for relevant demographic and clinical characteristics (Stan. β = −0.15, p <0.05). Conclusions: Results indicate that good patient-provider communication is associated with lower levels of lung cancer stigma, suggesting that improving patient-provider communication may be a good intervention target for reducing lung cancer stigma.

Original languageEnglish (US)
JournalSupportive Care in Cancer
DOIs
StateAccepted/In press - Nov 9 2015

Fingerprint

Lung Neoplasms
Communication
Demography
Health Personnel
Emotions
Cross-Sectional Studies
Smoking
Delivery of Health Care

Keywords

  • Lung cancer
  • Lung cancer stigma
  • Patient-provider communication

ASJC Scopus subject areas

  • Oncology

Cite this

Association between patient-provider communication and lung cancer stigma. / Shen, Megan Johnson; Hamann, Heidi A.; Thomas, Anna J.; Ostroff, Jamie S.

In: Supportive Care in Cancer, 09.11.2015.

Research output: Contribution to journalArticle

Shen, Megan Johnson ; Hamann, Heidi A. ; Thomas, Anna J. ; Ostroff, Jamie S. / Association between patient-provider communication and lung cancer stigma. In: Supportive Care in Cancer. 2015.
@article{e336bae97b5141c88d1f7737ac56b79e,
title = "Association between patient-provider communication and lung cancer stigma",
abstract = "Purpose: The majority (95 {\%}) of lung cancer patients report stigma, with 48 {\%} of lung cancer patients specifically reporting feeling stigmatized by their medical providers. Typically associated with the causal link to smoking and the historically poor prognosis, lung cancer stigma can be seen as a risk factor for poor psychosocial and medical outcomes in the context of lung cancer diagnosis and treatment. Thus, modifiable targets for lung cancer stigma-reducing interventions are needed. The present study sought to test the hypothesis that good patient-provider communication is associated with lower levels of lung cancer stigma. Methods: Lung cancer patients (n = 231) across varying stages of disease participated in a cross-sectional, multisite study designed to understand lung cancer stigma. Patients completed several survey measures, including demographic and clinical characteristics, a measure of patient-provider communication (Consumer Assessment of Healthcare Providers and Systems Program or CAHPS), and a measure of lung cancer stigma (Cataldo Lung Cancer Stigma Scale). Results: As hypothesized, results indicated that good patient-provider communication was associated with lower levels of lung cancer stigma (r = −0.18, p <0.05). These results remained significant, even when controlling for relevant demographic and clinical characteristics (Stan. β = −0.15, p <0.05). Conclusions: Results indicate that good patient-provider communication is associated with lower levels of lung cancer stigma, suggesting that improving patient-provider communication may be a good intervention target for reducing lung cancer stigma.",
keywords = "Lung cancer, Lung cancer stigma, Patient-provider communication",
author = "Shen, {Megan Johnson} and Hamann, {Heidi A.} and Thomas, {Anna J.} and Ostroff, {Jamie S.}",
year = "2015",
month = "11",
day = "9",
doi = "10.1007/s00520-015-3014-0",
language = "English (US)",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Association between patient-provider communication and lung cancer stigma

AU - Shen, Megan Johnson

AU - Hamann, Heidi A.

AU - Thomas, Anna J.

AU - Ostroff, Jamie S.

PY - 2015/11/9

Y1 - 2015/11/9

N2 - Purpose: The majority (95 %) of lung cancer patients report stigma, with 48 % of lung cancer patients specifically reporting feeling stigmatized by their medical providers. Typically associated with the causal link to smoking and the historically poor prognosis, lung cancer stigma can be seen as a risk factor for poor psychosocial and medical outcomes in the context of lung cancer diagnosis and treatment. Thus, modifiable targets for lung cancer stigma-reducing interventions are needed. The present study sought to test the hypothesis that good patient-provider communication is associated with lower levels of lung cancer stigma. Methods: Lung cancer patients (n = 231) across varying stages of disease participated in a cross-sectional, multisite study designed to understand lung cancer stigma. Patients completed several survey measures, including demographic and clinical characteristics, a measure of patient-provider communication (Consumer Assessment of Healthcare Providers and Systems Program or CAHPS), and a measure of lung cancer stigma (Cataldo Lung Cancer Stigma Scale). Results: As hypothesized, results indicated that good patient-provider communication was associated with lower levels of lung cancer stigma (r = −0.18, p <0.05). These results remained significant, even when controlling for relevant demographic and clinical characteristics (Stan. β = −0.15, p <0.05). Conclusions: Results indicate that good patient-provider communication is associated with lower levels of lung cancer stigma, suggesting that improving patient-provider communication may be a good intervention target for reducing lung cancer stigma.

AB - Purpose: The majority (95 %) of lung cancer patients report stigma, with 48 % of lung cancer patients specifically reporting feeling stigmatized by their medical providers. Typically associated with the causal link to smoking and the historically poor prognosis, lung cancer stigma can be seen as a risk factor for poor psychosocial and medical outcomes in the context of lung cancer diagnosis and treatment. Thus, modifiable targets for lung cancer stigma-reducing interventions are needed. The present study sought to test the hypothesis that good patient-provider communication is associated with lower levels of lung cancer stigma. Methods: Lung cancer patients (n = 231) across varying stages of disease participated in a cross-sectional, multisite study designed to understand lung cancer stigma. Patients completed several survey measures, including demographic and clinical characteristics, a measure of patient-provider communication (Consumer Assessment of Healthcare Providers and Systems Program or CAHPS), and a measure of lung cancer stigma (Cataldo Lung Cancer Stigma Scale). Results: As hypothesized, results indicated that good patient-provider communication was associated with lower levels of lung cancer stigma (r = −0.18, p <0.05). These results remained significant, even when controlling for relevant demographic and clinical characteristics (Stan. β = −0.15, p <0.05). Conclusions: Results indicate that good patient-provider communication is associated with lower levels of lung cancer stigma, suggesting that improving patient-provider communication may be a good intervention target for reducing lung cancer stigma.

KW - Lung cancer

KW - Lung cancer stigma

KW - Patient-provider communication

UR - http://www.scopus.com/inward/record.url?scp=84946780629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946780629&partnerID=8YFLogxK

U2 - 10.1007/s00520-015-3014-0

DO - 10.1007/s00520-015-3014-0

M3 - Article

C2 - 26553030

AN - SCOPUS:84946780629

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

ER -